+
Site Tour

AV VALVES Summit 2023 Trending Controversies Round 3: TA, TF in TMVR

What have we learned after 3 years of transcatheter mitral valve replacement (TMVR) with Tendyne™ and the future ahead with transfemoral (TF) options? Round 3 of the trending controversies session addresses this topic with Martin Andreas and Lars Søndergaard.

FIND OUT MORE ON AV VALVE SUMMIT 2023:

Watch on Demand videos

Related Videos

AV VALVES 2023:Decision Making in HF – Mitral

AV VALVES 2023: MR – MAC

AV VALVES 2023: TR – Big Gaps

AV VALVES 2023: The Genesis of TEER

AV VALVES 2023: HoloLens Technology

EuroPCR 2022: Leading clinical evidence

EACTS 2021: Transcatheter mitral valve implantation

EACTS 2021: MVR Guidelines update

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler

Javier's testimonial

AV VALVES 2023: Trending Topics – Timing

Echo course tricuspid TEER – cases

PCR London Valves 2022 – Treatment of Mitral Valve disease

TRENDING TOPICS

Epic Mitral – 10-Year Clinical Outcomes

Ten-Year Follow-Up of Mitral Valve Replacement With the Epic Porcine Valve

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline